Form 8-K - Current report:
SEC Accession No. 0001564590-21-000288
Filing Date
2021-01-05
Accepted
2021-01-05 17:19:09
Documents
3
Period of Report
2021-01-05
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K clsd-8k_20210105.htm 8-K 25887
2 GRAPHIC glcvmcqcnecy000001.jpg GRAPHIC 643
3 GRAPHIC glcvmcqcnecy000002.jpg GRAPHIC 643
  Complete submission text file 0001564590-21-000288.txt   29040
Mailing Address 900 NORTH POINT PARKWAY SUITE 200 ALPHARETTA 2Q 30005
Business Address 900 NORTH POINT PARKWAY SUITE 200 ALPHARETTA 2Q 30005 678-270-3631
Clearside Biomedical, Inc. (Filer) CIK: 0001539029 (see all company filings)

EIN.: 452437375 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37783 | Film No.: 21507137
SIC: 2834 Pharmaceutical Preparations